1. Introduction {#s0005}
===============

Inappropriately high thyroid hormone (TH) synthesis and secretion by the thyroid is the cause of hyperthyroidism. TH elevates the basal metabolic rate and tissue thermogenesis, and decreases systemic vascular resistance and cholesterol serum levels ([@b0060]). Thus, complications related to untreated hyperthyroidism include cardiovascular dysfunction, embolic events, atrial fibrillation, fragility fractures, osteoporosis and weight loss ([@b0010], [@b0015]). Hyperthyroidism prevalence is 0.2--1.6% overt and 0.7--1.0% subclinical ([@b0060], [@b0125]). Among Saudi adults, prevalence of hyperthyroidisms in both sexes was 2.8%, the highest prevalence was in females ([@b0005]).

Normal thyroid gland and anatomic variants can be routinely imaged by diagnostic imaging modalities including ultrasound (US), magnetic resonance imaging (MRI), computed tomography (CT) and scintigraphy (SC) ([@b0070]). Although, ultrasound has advantages of lack of radiation and easy availability, it is limited by operator dependency ([@b0040]). Also, in addition to morphological information obtained by US, thyroid SC visualizes active thyroid tissue distribution. Thus, SC general indications are indeed wide and include both single thyroid nodule, and multinodular goitre. When US is not able to visualize thyroid gland lower pole, SC is used to evaluate retrosternal goitre extent and in suspected ectopic thyroid ([@b0030]).

Now, it is well know that thyroid gland iodine uptake is attributed to sodium-iodide symporter ([@b0065]). Concerning thyroid function evaluation, thyroid cells iodine uptake is remains widely used by means of thyroid SC and radioiodine uptake test ([@b0055], [@b0100]). Thyroid SC practice and value in hyperthyroidism diagnosis is unsettled ([@b0105]). Diagnostic regimens using different imaging methods as well as their specificity and sensitivity vary depending on protocols used, physicians experience and patient's population ([@b0070]). The aim of the present research was to determine the usefulness of thyroid SC in comparison with TSH and US in patients diagnosed for hyperthyroidism.

2. Material and methods {#s0010}
=======================

2.1. Study design {#s0015}
-----------------

This cross sectional study was registered in King Faisal Specialist Hospital and Research Centre (KFSH and RC), Riyadh, Saudi Arabia. It was conducted over 15 months period from September 2017 to December 2018.

2.2. Patient's inclusion and exclusion criteria {#s0020}
-----------------------------------------------

This study included convenient patients sample (*n* = 50, 15 males and 35 females) including patients with any age (20--50 years) diagnosed primary as hyperthyroidism and were attending endocrine clinics at KFSH and RC. All cases have three clinical investigations (lab analysis, US and nuclear medicine examination). Exclusion criteria are previous radioactive iodine treatment, treatment with immunomodulatory drugs, major co-morbidity, ongoing anti-thyroid drug treatment for \>2 months, complete/partial thyroidectomy and pregnancy or breast-feeding.

2.3. Ethical statement {#s0025}
----------------------

This work was approved by the ethics committee of KFSH and RC and the institute review board of each participant. All patients were provided by questionnaire that explained study aims and importance and a written consent was attained from each participant.

2.4. Examinations {#s0030}
-----------------

All patients had clinical history suggestive of hyperthyroidism.

### 2.4.1. Ultrasonography {#s0035}

Neck US was performed for all patients using high-resolution US apparatus (HDI 5000 or iU 22; Philips Medical Systems, Bothell, WA, USA) with high frequency (7--15 MHz) linear-array transducer in supine position with hyperextended neck. It provides adequate penetration and high resolution image. Scanning is done both in transverse and longitudinal planes.

### 2.4.2. Thyroid scintigraphy {#s0040}

Two weeks prior to their thyroid investigation, all patients were placed on a low iodine diet (e.g. Iodine-containing vitamins and food supplements, whole eggs or yolks, sea-foods). Immediately before scanning, patients ingested water abundantly to clear any esophageal activity. Based on dose calculation, patients were given ^123^I dose of (0.2--0.5 mCi) for scan and ^131^I dose of 10 mCi for uptake. Also, patients were given ^99m^Tc dose of about 3--5 mCi. Scintillation camera (Philips Medical Systems, Andover, MA, USA) equipped with high-resolution, medium/high energy and parallel-hole collimator was used for determining sodium iodide (NaI) crystal uptake. Thyroid scintigraphy and uptake were performed 24 h after radioiodine, and 15--20 min after ^99m^TC injection.

### 2.4.3. Biochemical analysis {#s0045}

Thyroid stimulating hormone (TSH) serum levels were measured using fully automated Enzyme-Linked Immunosorbent Assay (ELISA) analyser using commercial ELISA Kits (Abcam, UK) with reference values of 0.5--6.5 m IU/l.

2.5. Statistical analysis {#s0050}
-------------------------

All statistical analysis was performed using SPSS (SPSS Inc., Chicago, IL, USA, version 17). The comparison between the three tests was based on the Proportion Correctly Classified (PCC) which reflects the total proportion of individuals that are correctly classified as having hyperthyroidism ([@b0135]). Agreement between post-scintigraphy diagnosis and US findings was examined using the kappa statistics. Interpretation of Kappa values was as follows: poor agreement (0--0.2), regular agreement (0.21--0.4), moderate agreement (0.41--0.6), good agreement (0.61--0.8) and very good agreement (0.81--1.0) ([@b0080]).

3. Results {#s0055}
==========

All patients (n = 50) included in this study had a clinical history suggestive of hyperthyroidism. In this study, all 50 patients underwent thyroid SC diagnosis, US diagnosis and laboratory test (TSH) measurement for diagnosis of hyperthyroidism.

US findings for 50 patients with hyperthyroidism were classified as multinodular goiter (MNG) with thyroid gland enlargement, normal gland (in shape and size), gland enlargement with no nodularity, Graves' disease, Solitary nodule, right and/or left lobes large nodules (\>1 cm each) and micronodularity with thyroiditis. The analysis was based on the PCC mentioned above. Among these patients, 96%, 48/50, had positive findings for hyperthyroidism with thyroid SC (95% CI; 96.0--99.5%); 84%, 42/50, had positive findings for hyperthyroidism by US (95% CI; 70.9--92.8%); and 56%, 28/50, had positive findings for hyperthyroidism by TSH measurement (95% CI; 41.3.0--70.0%) ([Table 1](#t0005){ref-type="table"}). Thyroid scintigraphy was superior to US and TSH test and provided valuable information regarding both thyroid physiology and anatomy and thus can play an integral role in hyperthyroidism diagnosis.Table 1Nuclear medicine versus ultrasound and biochemical findings in patients with hyperthyroidism.Hyperthyroidism presentHyperthyroidism absentTotal*Test results for thyroid SC diagnosis*Test positive48048Test negative202Total5000  *Test results for US*Test positive42042Test negative808Total5000  *Test results for laboratory TSH measurement*Test positive28028Test negative22022Total5000

Thyroid scintigraphy was correctly matched to US in 42 cases (84%) and mismatched in 8 patients (16%). There was very good overall agreement between thyroid scintigraphy diagnosis and US with a kappa score of 0·812 (*P* \< 0·0001), 95% CI (0·77--0·85). Also, in many cases scintigraphy provides considerably more functioning and anatomic details than ultrasound.

4. Discussion {#s0060}
=============

Usually, hyperthyroidism diagnosis is straightforward and typically include the combination of laboratory evaluation, physical findings and historical symptoms ([@b0120]). Thyroid function evaluation guidelines recommend measuring TSH first ([@b0115]). Also in hyperthyroidism patients, recent studies reemphasized the need for US as an essential part of the evaluation as thyroid gland morphology could be variable and nodules in these glands would need to be investigated. This consequently would significantly affect follow-up management plan and decision-making ([@b0130]).

Current role of nuclear scintigraphy using ^99m^Tc-pertechnetate or ^123/131^I is adjunctive rather than as first-line diagnostic method ([@b0110]). However, it gives valuable information regarding not only thyroid anatomy, but also it gives excellent functional information about the gland. This is in contrast to ultrasound, which provides information on gross morphology or biopsy that provides histological information. Therefore, thyroid scintigraphy can play integral role in hyperthyroidism diagnosis ([@b0020]). But, only few studies have specifically discussed this issue and thyroid scintigraphy value in hyperthyroidism diagnosis and management has long been the subject of debate ([@b0075], [@b0105]). Thus, this study aimed to evaluate the utility of scintigraphy in differential hyperthyroidism diagnosis in comparison to TSH testing and US.

In this study, TSH low serum levels detected in only 56% of patients with hyperthyroidism. In contrast, radioactive iodine uptake scans successfully evaluates thyroid gland function in 48/50 (96%) of hyperthyroidism patients even patients with normal TSH serum levels. Thyroid scintigraphy permits direct visualization of functional adenomatous thyroid tissue responsible for hyperthyroidism development. So, it will allow hyperthyroidism diagnosis before laboratory tests are consistently abnormal ([@b0020]).

The American and European thyroid associations guidelines recommend radionuclide scanning in patients with thyroid nodules only if serum TSH level is low ([@b0045], [@b0050]). But, this motive comes from expert opinions ([@b0090]) or small clinical studies ([@b0085]). In patients with thyroid nodule and normal TSH level in the absence of thyroid scintigraphy, there is a risk of performing fine needle aspiration cytology (FNAC) in unsuspected autonomously functioning thyroid nodules (AFTN) ([@b0095]). A study demonstrated that more than 70% of patients with an AFTN referred to the hospital had normal TSH level ([@b0025]).

Main thyroid scintiscanning uses includes the diagnosis of hyperthyroidism cause and the identification of normal and ectopic thyroid tissue ([@b0090]). In this study, thyroid scintigraphy was superior to US (90% *vs.* 84%) in identification of hyperthyroidism autecology. There was very good overall agreement between thyroid scintigraphy diagnosis and US (κ = 0.812, *P* \< 0.0001). Also, in many cases scintigraphy provides considerably more functioning and anatomic details than ultrasound.

In addition to the morphological information obtained from US, thyroid SC visualizes active thyroid tissue distribution \[5\]. Thus, SC general indications are quite wide and include both thyroid single nodule and multinodular goiter. Also, SC is used in evaluation suspected ectopic thyroid. When US is not able to visualize thyroid gland lower pole, scintigraphy is also used to evaluate retrosternal goiter extent ([@b0035]). Many studies recommended that scintigraphy may be indicated in Graves' disease differentiation from toxic nodular goitre and in thyroiditis diagnosis ([@b0090], [@b0105]). Although these studies found that scintigraphy in most cases given additional information over the diagnosis obtained from immunological and standard clinical data, they did not justify the routine use of scintigraphy in clinical practice ([@b0105]). Also, they assured that thyroid uptake scan has undoubtedly role in some clinical scenarios like factitious hyperthyroidism and acute thyroiditis ([@b0105]). Thyroid SC is non-invasive, simple, fast and cost effective method for hyperthyroidism evaluation ([@b0035]).

Some limitations of this study should be noted; it was a single-center study and external validity is required to support widespread changes in practice. Also, the small sample size may affect statistical power of the study.

In conclusion, by combining functional and anatomical information in one step, thyroid SC has the potential to provide superior information regarding hyperthyroidism and the potential to replace thyroid profile and US in hyperthyroidism investigation.
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